Zou Yong
Topic：Quality Risk Management: Beyond Existing Tools and Models
Presentation Summary：Quality risk management was introduced into the pharmaceutical industry along with the 2010 version of GMP in China; Internationally, Quality Risk Management was introduced by ICH as Q9 in 2005. In daily work practice, there is an increasing demand for quality risk management tools, and the general lack of learning and understanding of ICH Q9 in China has led to deviations in the understanding and use of quality risk management tools. I hope this sharing will give everyone a new understanding and understanding of quality risk management.
- Time：2021-10-20 17:05~17:50
- The expected time：45 minutes
- Meeting room：Aseptic Processing Sub-forum
Mr. ZOU graduated from the department of chemistry of Peking University and went to the National University of Singapore for his master's degree. Mr. ZOU has nearly 20 years of working experience in the pharmaceutical industry, successively engaged in R&D, production management and quality management, including different areas such as chemical drugs, Chinese Traditional Drugs, biological products and cell therapy. He has led the company to pass a series of international certifications such as WHO PQ. Now Mr. ZOU is mainly engaged in quality management consultation for pharmaceutical companies, including GMP, quality management system, quality risk management, qualification and validation, international GMP certification, quality management tools (deviation, CAPA, change, etc.), single-use system, vaccine production, etc. Since 2017, he has been employed as a GMP consultant by Beijing NMPA.
评论
加载更多